SO
About
Sofar develops its own line of products, expanding its production to include dietary supplements and medical devices. In 1985 Sofar launches Sofargen, a topical dressing containing silver sulfadiazine. The WHO places it on its list of 200 essential drugs. It was followed by some more products that they developed during their years of experimentation. Such products may include Pensacola, Enterolactis, Cistiflu, and many more. SOFAR AMERICAS Inc. is established in the USA in the year 2016.
Investment Focus
- Location
- Petaluma, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Sofar
Search Investors